Overview
Louis Lebreton practices practicing medicine in Bordeaux, France.
Mr. Lebreton is highly rated in 1 condition, according to our data. His clinical expertise encompasses Acute Intermittent Porphyria, Rabson-Mendenhall Syndrome, Donohue Syndrome, and Hypotonia.
He is actively involved in clinical research, co-authoring 24 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Louis Lebreton
Is Louis Lebreton a top-rated expert for Acute Intermittent Porphyria?
MediFind is an objective health platform that identifies experts based on real-world data. Louis Lebreton is classified as an Advanced expert for Acute Intermittent Porphyria, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Louis Lebreton participate in research or clinical trials?
Yes. Louis Lebreton has published 24 articles and abstracts on conditions like Acute Intermittent Porphyria. You can view a list of Louis Lebreton's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Intermittent PorphyriaMr. Lebreton isAdvanced. Learn about Acute Intermittent Porphyria.
- Experienced
- Acute Hepatic Porphyria (AHP)Mr. Lebreton isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Alpha-1 Antitrypsin Deficiency (AATD)Mr. Lebreton isExperienced. Learn about Alpha-1 Antitrypsin Deficiency (AATD).
- Aplasia Cutis CongenitaMr. Lebreton isExperienced. Learn about Aplasia Cutis Congenita.
- Bardet-Biedl SyndromeMr. Lebreton isExperienced. Learn about Bardet-Biedl Syndrome.
- Brachydactyly Mononen TypeMr. Lebreton isExperienced. Learn about Brachydactyly Mononen Type.
- ChondrodystrophyMr. Lebreton isExperienced. Learn about Chondrodystrophy.
- Clouston SyndromeMr. Lebreton isExperienced. Learn about Clouston Syndrome.
- Donohue SyndromeMr. Lebreton isExperienced. Learn about Donohue Syndrome.
- Ectodermal DysplasiasMr. Lebreton isExperienced. Learn about Ectodermal Dysplasias.
- Glycine EncephalopathyMr. Lebreton isExperienced. Learn about Glycine Encephalopathy.
- Hereditary SpherocytosisMr. Lebreton isExperienced. Learn about Hereditary Spherocytosis.
- HomocystinuriaMr. Lebreton isExperienced. Learn about Homocystinuria.
- Hypohidrotic Ectodermal DysplasiaMr. Lebreton isExperienced. Learn about Hypohidrotic Ectodermal Dysplasia.
- HypotoniaMr. Lebreton isExperienced. Learn about Hypotonia.
- Metabolic AcidosisMr. Lebreton isExperienced. Learn about Metabolic Acidosis.
- Microcephalic Osteodysplastic Primordial Dwarfism Type 1 (MOPD1)
- Microcephalic Osteodysplastic Primordial Dwarfism Type 2 (MOPD2)
- Multiple Carboxylase DeficiencyMr. Lebreton isExperienced. Learn about Multiple Carboxylase Deficiency.
- PorphyriaMr. Lebreton isExperienced. Learn about Porphyria.
- Prader-Willi SyndromeMr. Lebreton isExperienced. Learn about Prader-Willi Syndrome.
- Rabson-Mendenhall SyndromeMr. Lebreton isExperienced. Learn about Rabson-Mendenhall Syndrome.
- Schwartz-Jampel SyndromeMr. Lebreton isExperienced. Learn about Schwartz-Jampel Syndrome.
- Subcutaneous EmphysemaMr. Lebreton isExperienced. Learn about Subcutaneous Emphysema.
- X-Linked Spondyloepiphyseal Dysplasia TardaMr. Lebreton isExperienced. Learn about X-Linked Spondyloepiphyseal Dysplasia Tarda.